BACKGROUND: Apamin-sensitive K currents (I(KAS)) are upregulated in heart failure. We hypothesize that apamin can flatten action potential duration restitution (APDR) curve and can reduce ventricular fibrillation duration in failing ventricles. METHODS AND RESULTS: We simultaneously mapped membrane potential and intracellular Ca (Ca(i)) in 7 rabbit hearts with pacing-induced heart failure and in 7 normal hearts. A dynamic pacing protocol was used to determine APDR at baseline and after apamin (100 nmol/L) infusion. Apamin did not change APD(80) in normal ventricles, but prolonged APD(80) in failing ventricles at either long (≥300 ms) or short (≤170 ms) pacing cycle length, but not at intermediate pacing cycle length. The maximal slope of APDR curve was 2.03 (95% confidence interval, 1.73-2.32) in failing ventricles and 1.26 (95% confidence interval, 1.13-1.40) in normal ventricles at baseline (P=0.002). After apamin administration, the maximal slope of APDR in failing ventricles decreased to 1.43 (95% confidence interval, 1.01-1.84; P=0.018), whereas no significant changes were observed in normal ventricles. During ventricular fibrillation in failing ventricles, the number of phase singularities (baseline versus apamin, 4.0 versus 2.5), dominant frequency (13.0 versus 10.0 Hz), and ventricular fibrillation duration (160 versus 80 s) were all significantly (P<0.05) decreased by apamin. CONCLUSIONS: Apamin prolongs APD at long and short, but not at intermediate pacing cycle length in failing ventricles. I(KAS) upregulation may be antiarrhythmic by preserving the repolarization reserve at slow heart rate, but is proarrhythmic by steepening the slope of APDR curve, which promotes the generation and maintenance of ventricular fibrillation.
BACKGROUND: Apamin-sensitive K currents (I(KAS)) are upregulated in heart failure. We hypothesize that apamin can flatten action potential duration restitution (APDR) curve and can reduce ventricular fibrillation duration in failing ventricles. METHODS AND RESULTS: We simultaneously mapped membrane potential and intracellular Ca (Ca(i)) in 7 rabbit hearts with pacing-induced heart failure and in 7 normal hearts. A dynamic pacing protocol was used to determine APDR at baseline and after apamin (100 nmol/L) infusion. Apamin did not change APD(80) in normal ventricles, but prolonged APD(80) in failing ventricles at either long (≥300 ms) or short (≤170 ms) pacing cycle length, but not at intermediate pacing cycle length. The maximal slope of APDR curve was 2.03 (95% confidence interval, 1.73-2.32) in failing ventricles and 1.26 (95% confidence interval, 1.13-1.40) in normal ventricles at baseline (P=0.002). After apamin administration, the maximal slope of APDR in failing ventricles decreased to 1.43 (95% confidence interval, 1.01-1.84; P=0.018), whereas no significant changes were observed in normal ventricles. During ventricular fibrillation in failing ventricles, the number of phase singularities (baseline versus apamin, 4.0 versus 2.5), dominant frequency (13.0 versus 10.0 Hz), and ventricular fibrillation duration (160 versus 80 s) were all significantly (P<0.05) decreased by apamin. CONCLUSIONS: Apamin prolongs APD at long and short, but not at intermediate pacing cycle length in failing ventricles. I(KAS) upregulation may be antiarrhythmic by preserving the repolarization reserve at slow heart rate, but is proarrhythmic by steepening the slope of APDR curve, which promotes the generation and maintenance of ventricular fibrillation.
Authors: Valentino Piacentino; Christopher R Weber; Xiongwen Chen; Jutta Weisser-Thomas; Kenneth B Margulies; Donald M Bers; Steven R Houser Journal: Circ Res Date: 2003-02-20 Impact factor: 17.367
Authors: Su-Kiat Chua; Po-Cheng Chang; Mitsunori Maruyama; Isik Turker; Tetsuji Shinohara; Mark J Shen; Zhenhui Chen; Changyu Shen; Michael Rubart-von der Lohe; John C Lopshire; Masahiro Ogawa; James N Weiss; Shien-Fong Lin; Tomohiko Ai; Peng-Sheng Chen Journal: Circ Res Date: 2011-02-24 Impact factor: 17.367
Authors: Chih-Chieh Yu; Christopher Corr; Changyu Shen; Richard Shelton; Mrinal Yadava; Isaac B Rhea; Susan Straka; Michael C Fishbein; Zhenhui Chen; Shien-Fong Lin; John C Lopshire; Peng-Sheng Chen Journal: Circ Arrhythm Electrophysiol Date: 2015-04-23
Authors: Tae Yun Kim; Radmila Terentyeva; Karim H F Roder; Weiyan Li; Man Liu; Ian Greener; Shanna Hamilton; Iuliia Polina; Kevin R Murphy; Richard T Clements; Samuel C Dudley; Gideon Koren; Bum-Rak Choi; Dmitry Terentyev Journal: Cardiovasc Res Date: 2017-03-01 Impact factor: 10.787
Authors: Mu Chen; Dong-Zhu Xu; Adonis Z Wu; Shuai Guo; Juyi Wan; Dechun Yin; Shien-Fong Lin; Zhenhui Chen; Michael Rubart-von der Lohe; Thomas H Everett; Zhilin Qu; James N Weiss; Peng-Sheng Chen Journal: JCI Insight Date: 2018-11-15
Authors: Juyi Wan; Mu Chen; Zhuo Wang; Thomas H Everett; Michael Rubart-von der Lohe; Changyu Shen; Zhilin Qu; James N Weiss; Penelope A Boyden; Peng-Sheng Chen Journal: Heart Rhythm Date: 2018-11-13 Impact factor: 6.343